New Trends In Oligotherapeutics

The oligotherapeutics market has expanded in size, disease indications and exploratory molecules in recent years, As oligo API portfolios have grown more diverse, CDMOs are challenged to provide a toolbox of established and new synthesis, purification and scale-up solutions to satisfy complex molecule and customer demands. Join Daniel Bachmann to learn how CDMOs can prepare to meet industry demand.